Proposed Data Collection Submitted for Public Comment and Recommendations, 74192-74193 [2023-23858]
Download as PDF
74192
Federal Register / Vol. 88, No. 208 / Monday, October 30, 2023 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–23857 Filed 10–27–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–24AH; Docket No. CDC–2023–
0087]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
Government information, invites the
general public and other Federal
agencies to comment on a proposed
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled IRB Authorization Agreement for
Human Research. The purpose of the
data collection is to keep track of, and
provide regulatory oversight for, those
institutions that have elected to rely on
the CDC IRB’s review of research
studies.
SUMMARY:
CDC must receive written
comments on or before December 29,
2023.
DATES:
You may submit comments,
identified by Docket No. CDC–2023–
0087 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
ADDRESSES:
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
IRB Authorization Agreement for
Human Research—New—Office of
Science (OS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The CDC Human Research Protection
Office (HRPO) often receives requests
from outside institutions seeking to rely
on the CDC Institutional Review Board
(IRB) for review of a research study.
This arrangement also allows multiple
institutions to use, or rely on, the CDC
IRB for centralized review and approval
of research studies instead of review by
the site-specific IRBs, which helps
reduce duplication of effort, delays, and
expenses.
To meet regulatory requirements,
institutions that elect to rely on the CDC
IRB’s review of research studies are
required to complete a CDC IRB
Authorization Agreement for Human
Research and a Local Context Survey.
The agreement and the survey will be
used to provide regulatory oversight for
human subjects research, maintain
records and track those institutions that
have elected to rely on the CDC IRB for
review.
CDC requests OMB approval for an
estimated 450 annual burden hours.
There is no cost to respondents other
than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
khammond on DSKJM1Z7X2PROD with NOTICES
Type of respondent
Hospital/Academic Institutions/IRB
Administrators.
Hospital/Academic Institutions/IRB
Administrators.
Total ...........................................
VerDate Sep<11>2014
18:18 Oct 27, 2023
Number of
respondents
Form name
Number
responses per
respondent
Avg. burden
per response
(in hrs.)
Total burden
(in hrs.)
CDC IRB Authorization Agreement
for Human Research (for review,
completion and submission to
CDC).
Local context survey (for completion
and submission to CDC.
150
1
1
150
150
1
2
300
...........................................................
........................
........................
........................
450
Jkt 262001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
E:\FR\FM\30OCN1.SGM
30OCN1
Federal Register / Vol. 88, No. 208 / Monday, October 30, 2023 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–23858 Filed 10–27–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–1078; Docket No. CDC–2023–
0086]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
Government information, invites the
general public and other Federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled The Division of
Workforce Development (DWD)
Fellowship Alumni Assessment.
Information will be collected from
graduates of selected public health
fellowships to assess the impact of
fellowship programs and improve their
management.
DATES: CDC must receive written
comments on or before December 29,
2023.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2023–
0086 by any of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
khammond on DSKJM1Z7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
18:18 Oct 27, 2023
Jkt 262001
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
FOR FURTHER INFORMATION CONTACT:
Proposed Project
The Division of Workforce
Development (DWD) Fellowship
Alumni Assessment (OMB Control No.
0920–1078, Exp. 02/29/2024)—
Revision—National Center for State,
Tribal, Local, and Territorial Public
Health Infrastructure and Workforce
(NCSTLTPHIW), Centers for Disease
Control and Prevention (CDC).
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
74193
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) works to protect
America from health, safety and security
threats, both foreign and in the U.S.
CDC strives to fulfill this mission, in
part, through a competent and capable
public health workforce. One
mechanism for developing the public
health workforce is through fellowship
programs like those sponsored and
supported by the Division of Workforce
Development (DWD).
A robust public health workforce has
sufficient workforce, organizational, and
systems capacity to deliver essential
public health services and protect the
public’s health. In 2023, after a CDC
reorganization agency-wide, a number
of CDC career fellowships were
consolidated within one new division,
DWD, which has a lead role in public
health workforce development. Across
all of its branches, DWD manages or
supports many full-time, cross-cutting
career fellowship programs that support
CDC and State, Tribal, local, and
Territorial health departments, and
partner organizations. Through these
programs, DWD strives to provide
quality training for current and future
members of the public health workforce
to ensure they have foundational and
contemporary public health skills.
Nearly all these programs serve as a
pathway to CDC career communities
and are an important source of supply
for the public health workforce.
In 2015, CDC obtained OMB approval
to conduct follow-up surveys of alumni
who had completed the Public Health
Associate Program (PHAP) (OMB
Control No. 0920–1078). Findings from
the PHAP alumni surveys have
improved CDC’s understanding of
alumni retention and career progression
in the public health workforce and have
informed management of the PHAP. In
the current Revision, CDC proposes to
build on lessons learned in PHAP
fellowship evaluation. CDC will
broaden the scope of information
collection to accommodate the full
portfolio of DWD fellowships, which
currently include the Epidemiology
Elective Program (EEP), Evaluation
Fellowship (EF), Epidemic Intelligence
Service (EIS), CDC E-Learning Institute,
Future Leaders in Infectious and Global
Health Threats (FLIGHT), Laboratory
Leadership Service (LLS), CDC Steven
M. Teutsch Prevention Effectiveness
(PE) Fellowship, Preventive Medicine
Residency and Fellowship, Population
Health Training in Place Program
(PHTPP), Science Ambassador
Fellowship (SAF), and PHAP. In
addition to expanding the respondent
E:\FR\FM\30OCN1.SGM
30OCN1
Agencies
[Federal Register Volume 88, Number 208 (Monday, October 30, 2023)]
[Notices]
[Pages 74192-74193]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23858]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-24-24AH; Docket No. CDC-2023-0087]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of Government information, invites the general public and other
Federal agencies to comment on a proposed information collection, as
required by the Paperwork Reduction Act of 1995. This notice invites
comment on a proposed information collection project titled IRB
Authorization Agreement for Human Research. The purpose of the data
collection is to keep track of, and provide regulatory oversight for,
those institutions that have elected to rely on the CDC IRB's review of
research studies.
DATES: CDC must receive written comments on or before December 29,
2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0087 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
IRB Authorization Agreement for Human Research--New--Office of
Science (OS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The CDC Human Research Protection Office (HRPO) often receives
requests from outside institutions seeking to rely on the CDC
Institutional Review Board (IRB) for review of a research study. This
arrangement also allows multiple institutions to use, or rely on, the
CDC IRB for centralized review and approval of research studies instead
of review by the site-specific IRBs, which helps reduce duplication of
effort, delays, and expenses.
To meet regulatory requirements, institutions that elect to rely on
the CDC IRB's review of research studies are required to complete a CDC
IRB Authorization Agreement for Human Research and a Local Context
Survey. The agreement and the survey will be used to provide regulatory
oversight for human subjects research, maintain records and track those
institutions that have elected to rely on the CDC IRB for review.
CDC requests OMB approval for an estimated 450 annual burden hours.
There is no cost to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number Avg. burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Hospital/Academic Institutions/ CDC IRB 150 1 1 150
IRB Administrators. Authorization
Agreement for
Human Research
(for review,
completion and
submission to
CDC).
Hospital/Academic Institutions/ Local context 150 1 2 300
IRB Administrators. survey (for
completion and
submission to
CDC.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 450
----------------------------------------------------------------------------------------------------------------
[[Page 74193]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-23858 Filed 10-27-23; 8:45 am]
BILLING CODE 4163-18-P